Authors


Marta Stevanovic, MD, MSc

Latest:

Treatment and technology: The future of retina care

How robotics and gene therapies are shaping retina research, now and in the days to come


Dr Michael Savetsky

Latest:

Real-world outcomes validate intraocular drug delivery method

Evidence from clinical trials and real-world situations demonstrates the effectiveness and convenience of intraocular drugs to control postoperative inflammation.


Prof. Günther Rudolph

Latest:

First-ever retinal gene therapy: Does real-world experience back its use?

Recent reports of retinal atrophy have raised concerns on potential long-term safety.


Veeral Sheth, MD, MBA, FACS, FASRS

Latest:

Gene therapy for managing neovascular macular degeneration

Gene therapy for nAMD represents significant advancements in the treatment of retinal conditions



Dr Roberto Gallego-Pinazo

Latest:

COVID-19 presents opportunities for new directions in ophthalmology

COVID-19 has had a significant impact on the entire global community. As we look to the future to advance the provision of eyecare excellence, opportunities for innovation must be embraced and new, patient-centric ways of managing clinical practices adopted.


Advertorial

Latest:

Broadening the benefits of iCare EIDON retinal imaging with the new Ultra-Wide Field Module

This article is produced by iCare Finland for healthcare professionals and is not intended to provide medical advice and/or treatment guidance. This website is not country-specific and therefore may contain information which is not applicable to your country.


José María Martínez de la Casa, MD

Latest:

Pinpointing a first-line treatment for glaucoma

Laser surgery is an appropriate adjunctive therapy across the continuum of glaucoma care, as well as a safe option for patients who also have cataracts and other complicating factors


Dr Neda Shamie

Latest:

New horizons in interventional glaucoma

Novel procedures may hold greater appeal for cataract and refractive surgeons


Dr Jeffrey Gemi

Latest:

Tried and tested therapeutic options for meibomian gland dysfunction

Methods using a combination of non-invasive thermal treatments and meibomian gland expression seem to be particularly effective.


Prof. Siegfried Priglinger

Latest:

Early intervention is crucial for long-term outcomes in paediatric gene therapy

At the Retina World Congress, we spoke with Siegfried Priglinger, MD, about ensuring the best outcomes for preschool-aged patients


Dr James G. Chelnis

Latest:

Driving practice growth: The connection between dry eye and aesthetics

Patients appreciate the convenience and aesthetic improvements of light-based dry eye treatment, and it can also be applied elsewhere on the face.


Roy Schwartz, MD, PhD

Latest:

Unveiling genetic distinctions between reticular pseudodrusen and drusen

Insights from a genome-wide association study identify novel genetic loci


Dr Carmen Bilbao

Latest:

Examining the link between neurodevelopmental disorders and visual problems

Children with certain neurodevelopmental disorders show altered ocular movements and a more reduced amplitude of accommodation, however, vision problems are not always present in these children and so cannot be considered an aetiological factor.


Albert J. Augustin, MD

Latest:

What's missing in patient education?

A different approach better serves patients with diabetic retinopathy


Dr Sjoerd Elferink

Latest:

Ophthalmology and the climate crisis: Time to take responsibility

The healthcare sector has high greenhouse gas emissions, to which ophthalmology is a significant contributor. Reducing waste, reusing instruments and medication and increasing our use of telemedicine can all contribute to reducing the carbon footprint of our specialty.


David Hutton

Latest:

Charles Wykoff, MD, PhD, presents on diabetic retinopathy and "the dream of reperfusion" at Floretina ICOOR 2024

Dr Wykoff addressed the top three questions retina specialists have about retinal non-perfusion



Dr. Luca Rossetti

Latest:

Setting a New Standard in Automated Tracked Perimetry

Innovative new features build on the benefits of the iCare COMPASS Automated Perimeter




Dr Sri Ganesh, MS, DNB

Latest:

Myth or reality? Corneal refractive surgery to manage presbyopic patients

A corneal refractive technique can combine monovision and extended depth of field to create a wide, seamless range of functional vision. This can provide independence from spectacles.


Dr Arun C. Gulani

Latest:

LaZrPlastique technique provides a 'non cutting' edge over LASIK

Dr Arun C. Gulani explains how his corneal surface technique offers a contrast to cutting procedures without risk, pain or drama.


Marc Labetoulle, MD, PhD

Latest:

New dry eye disease study compares two preservative-free artificial tear drops

Research findings from the multicentre clinical study were presented at the European Society of Ophthalmology (SOE) meeting in Lisbon, Portugal


David Bearden

Latest:

Retinal imaging to detect Alzheimer disease: machine learning model

An interdisciplinary team at Duke University has developed a proof-of-concept machine learning model capable of detecting symptomatic Alzheimer disease using multimodal retinal imaging data.


Prof. Stylianos Michalakis

Latest:

First-ever retinal gene therapy: Does real-world experience back its use?

Recent reports of retinal atrophy have raised concerns on potential long-term safety.


Dr Sebastian B. Heersink

Latest:

Combining laser with minimally invasive glaucoma surgery to impact IOP

Prompt, careful use of laser-based treatment minimises postoperative adverse effects.


Mr Neil Barnes, BSc(hons) MCOptom DipTp(IP)

Latest:

IOL design puts a new spin on vision

Advancements in lens technology reflect the growing popularity of multifocal lenses


Dr Jayanth Sridhar

Latest:

A window into the world of academic retina practice today

Dr Jayanth Sridhar shares a day in the life of an academic retina specialist.


Dr Marc Mathias

Latest:

Paediatric ophthalmologists target inherited retinal diseases

With at least 24 inherited retinal disease (IRD) clinical trials ongoing in the United States, and additional studies of stem cell therapy in several IRD indications, hope is on the horizon for many patients.

© 2025 MJH Life Sciences

All rights reserved.